RecruitingPhase 3NCT07037433
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Sponsor: Amgen
Topeka, KS · +139 more sites
7 recruiting obesity studies with a site in Topeka, KS.
Sponsor: Amgen
Topeka, KS · +139 more sites
Sponsor: Eli Lilly and Company
Topeka, KS · +39 more sites
Sponsor: Eli Lilly and Company
Topeka, KS · +79 more sites
Sponsor: Eli Lilly and Company
Topeka, KS · +49 more sites
Sponsor: Novo Nordisk A/S
Topeka, KS · +33 more sites
Sponsor: Novo Nordisk A/S
Newton, KS · Topeka, KS · +97 more sites
Sponsor: Eli Lilly and Company
Topeka, KS · +40 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.